Registro:

Referencias:

• Cines, D.B., Polak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., Pober, J.S., Stern, D.M., Endothelial cells in physiology and in the pathophysiology of vascular disorders (1998) Blood, 91, pp. 3527-3561
• DeMeyer, G.R.Y., Herman, A.G., Vascular endothelial dysfunction (1997) Prog Cardiovasc Dis, 39, pp. 325-342
• Moncada, S., Higgs, A., The L-arginine-nitric oxide pathway (1993) N Engl J Med, 27, pp. 2002-2011
• Stoiser, B., Maca, T., Thalammer, F., Hollenstein, U., El Menyawi, I., Burgmann, H., Serum nitrate concentration in patients with peripheral arterial occlusive disease (1999) Vasa, 28, pp. 181-184
• Ferlito, S., Gallina, M., Nitrite plasma levels in type 1 and 2 diabetes with and without complications (1998) Panminerva Med, 40, pp. 304-308
• Celermajer, D.S., Endothelial dysfunction: Does it matter? Is it reversible? (1997) JACC, 30, pp. 325-333
• Shimokawa, H., Endothelial dysfunction in hypertension (1998) J Atheroscler Thromb, 4, pp. 118-127
• Stehouwer, C.D.A., Schaper, N.C., The pathogenesis of vascular complications of diabetes mellitus: One voice or many? (1996) Eur J Clin Invest, 26, pp. 535-543
• Schmidt, A., Hori, O., Brett, J., Cellular receptors for AGEs: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis on vascular lesions (1994) Arterioscler Thromb, pp. 1521-1528
• Ferrannini, E., Haffner, S.M., Stern, M.P., Essential hypertension: An insulin resistence state (1990) Cardiovasc Pharmacol, 15, pp. 18-25
• Ferrannini, E., Buzzigoli, G., Bonadonna, R., Insulin resistance in essential hypertension (1987) N Engl J Med, 317, pp. 350-357
• DeFronzo, R.A., Ferrannini, E., Insulin resistance: A multifacetic syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease (1991) Diabetes Care, 14, pp. 173-194
• Tooke, J.E., Hannemann, M.M., Adverse endothelial function and the insulin resistance syndrome (2000) J Intern Med, 247, pp. 425-431
• Tachoepe, D., Rolsen, P., Schripper, B., Platelets in diabetes: The role in the hemostatic regulation in atherosclerosis (1993) Semin Thromb Haemostasis, 19, pp. 122-128
• Mc Ever, P.R., GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium (1991) J Cell Biochem, 45, pp. 156-161
• Furie, B., Furie, B.C., The Molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: Role of P-selectin and the P-selectin ligand PSGL-1 (1995) Thromb Haemostasis, 74, pp. 224-227
• Fijnheer, R., Frijns, C.J., Korteweg, J., Rommes, H., Peters, J.H., Sixma, J.J., Nieuwenhuis, H.K., The origin of P-selectin as a circulating plasma protein (1997) Thromb Haemostasis, 77, pp. 1081-1085
• Blann, A.D., Lip, G.Y.H., Beevers, D.G., McCollum, C.N., Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers (1997) Thromb Haemostasis, 77, pp. 1077-1080
• Lip, G., Blann, A., Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? (1997) Cardiovasc Res, 34, pp. 255-265
• Mantovani, A., Bussolino, F., Dejana, E., Cytokine regulation of enthotelial cell function (1992) FASEB J, 6, pp. 2591-2599
• The sixth report of the Joint National Commmittee on Detection, Evaluation and Treatment of High Pressure (JNC VI) (1997) Arch Intern Med, 157, pp. 2413-2446
• Moshage, H., Kok, B., Huizenga, J.R., Jansen, P.L., Nitrite and nitrate determination in plasma: A critical evaluation (1995) Clin Chem, 41, pp. 892-896
• Michelson, A.D., Platelet activation by thrombine can be directely measured in whole blood through the use of peptide GPRP and flow cytometry: Methods and clinical applications (1994) Blood Coagulation Fibrinolysis, 5, pp. 121-131
• Brownlee, M., Advanced protein glycosylation in diabetes and aging (1995) Annu Rev Med, 46, pp. 223-234
• Bucala, R., Tracey, K.J., Cerami, A., Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes (1991) J Clin Invest, 87, pp. 432-438
• Kaplan, N.M., Primary hypertension: Pathogenesis (1998) Clinical hypertension. 7th ed., pp. 41-99. , Kaplan NM, editor. Baltimore, MD: Williams and Wilkins
• Hausberg, M., Hoffman, R.P., Somers, V.K., Contrasting autonomic and hemodinamic effects of insulin in healthy elderly versus young subjects (1997) Hypertension, 29, pp. 700-705
• Cleland, S.J., Petrie, J.R., Small, M., Elliott, H.L., Connell, J.M., Insulin action is associated with endothelial function in hypertension and type 2 diabetes (2000) Hypertension, 35, pp. 507-511
• Radomski, M.W., Moncada, S., Regulation of vascular homeostasis by nitric oxide (1993) Thromb Haemostasis, 70, pp. 36-41
• Li, H., Fostermann, U., Nitric oxide in the pathogenesis of vascular disease (2000) J Pathol, 190, pp. 244-254
• Wu, C.-C., Yen, M.-H., Higher level of plasma nitric oxide in spontaneously hypertensive rats (1999) Am J Hypertens, 12, pp. 476-482
• Nava, E., Farré, A., Moreno, C., Casado, S., Moreau, P., Cosentino, F., Lüscher, T.F., Alterations to the nitric oxide pathway in the spontaneously hypertensive rat (1998) J Hypertens, 16, pp. 609-615
• Anggard, E., Nitric oxide: Mediator, murderer and medicine (1994) Lancet, 343, pp. 1199-1206
• Kodja, G., Harrison, D., Interaction between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure (1999) Cardiovasc Res, 43, pp. 562-571
• Vallejo, S., Angulo, J., Periro, C., Nevado, J., Sanchez-Ferrer, A., Petidier, R., Sanchez-Ferrer, C.F., Rodriguez-Manas, L., Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels (2000) Diabetologia, 43, pp. 83-90

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------